The Role of Chemokine Receptors in Renal Fibrosis.

2区 医学 Q1 Biochemistry, Genetics and Molecular Biology Reviews of Physiology Biochemistry and Pharmacology Pub Date : 2020-01-01 DOI:10.1007/112_2020_21
Fenglei Wu, Chi Sun, Jianquan Lu
{"title":"The Role of Chemokine Receptors in Renal Fibrosis.","authors":"Fenglei Wu,&nbsp;Chi Sun,&nbsp;Jianquan Lu","doi":"10.1007/112_2020_21","DOIUrl":null,"url":null,"abstract":"<p><p>Renal fibrosis is the final pathological process common to any ongoing, chronic kidney injury or maladaptive repair. Renal fibrosis is considered to be closely related to various cell types, such as fibroblasts, myofibroblasts, T cells, and other inflammatory cells. Multiple types of cells regulate renal fibrosis through the recruitment, proliferation, and activation of fibroblasts, and the production of the extracellular matrix. Cell trafficking is orchestrated by a family of small proteins called chemokines. Chemokines are cytokines with chemotactic properties, which are classified into 4 groups: CXCL, CCL, CX3CL, and XCL. Similarly, chemokine receptors are G protein-coupled seven-transmembrane receptors classified into 4 groups: XCR, CCR, CXCR, and CX3CR. Chemokine receptors are also implicated in the infiltration, differentiation, and survival of functional cells, triggering inflammation that leads to fibrosis development. In this review, we summarize the different chemokine receptors involved in the processes of fibrosis in different cell types. Further studies are required to identify the molecular mechanisms of chemokine signaling that contribute to renal fibrosis.</p>","PeriodicalId":21169,"journal":{"name":"Reviews of Physiology Biochemistry and Pharmacology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/112_2020_21","citationCount":"9","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reviews of Physiology Biochemistry and Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/112_2020_21","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 9

Abstract

Renal fibrosis is the final pathological process common to any ongoing, chronic kidney injury or maladaptive repair. Renal fibrosis is considered to be closely related to various cell types, such as fibroblasts, myofibroblasts, T cells, and other inflammatory cells. Multiple types of cells regulate renal fibrosis through the recruitment, proliferation, and activation of fibroblasts, and the production of the extracellular matrix. Cell trafficking is orchestrated by a family of small proteins called chemokines. Chemokines are cytokines with chemotactic properties, which are classified into 4 groups: CXCL, CCL, CX3CL, and XCL. Similarly, chemokine receptors are G protein-coupled seven-transmembrane receptors classified into 4 groups: XCR, CCR, CXCR, and CX3CR. Chemokine receptors are also implicated in the infiltration, differentiation, and survival of functional cells, triggering inflammation that leads to fibrosis development. In this review, we summarize the different chemokine receptors involved in the processes of fibrosis in different cell types. Further studies are required to identify the molecular mechanisms of chemokine signaling that contribute to renal fibrosis.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
趋化因子受体在肾纤维化中的作用。
肾纤维化是任何持续的慢性肾损伤或不适应修复的最终病理过程。肾纤维化被认为与多种细胞类型密切相关,如成纤维细胞、肌成纤维细胞、T细胞和其他炎症细胞。多种类型的细胞通过成纤维细胞的募集、增殖和激活以及细胞外基质的产生来调节肾纤维化。细胞运输是由一组被称为趋化因子的小蛋白质精心安排的。趋化因子是具有趋化特性的细胞因子,分为CXCL、CCL、CX3CL和XCL 4类。同样,趋化因子受体是G蛋白偶联的七跨膜受体,分为4类:XCR、CCR、CXCR和CX3CR。趋化因子受体还参与功能细胞的浸润、分化和存活,引发炎症,导致纤维化的发生。在这篇综述中,我们总结了不同细胞类型中参与纤维化过程的不同趋化因子受体。需要进一步的研究来确定趋化因子信号传导导致肾纤维化的分子机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Reviews of Physiology Biochemistry and Pharmacology
Reviews of Physiology Biochemistry and Pharmacology 医学-生化与分子生物学
CiteScore
11.40
自引率
0.00%
发文量
5
审稿时长
>12 weeks
期刊介绍: The highly successful Reviews of Physiology, Biochemistry and Pharmacology continue to offer high-quality, in-depth reviews covering the full range of modern physiology, biochemistry and pharmacology. Leading researchers are specially invited to provide a complete understanding of the key topics in these archetypal multidisciplinary fields. In a form immediately useful to scientists, this periodical aims to filter, highlight and review the latest developments in these rapidly advancing fields.
期刊最新文献
Cell-to-Cell Crosstalk: A New Insight into Pulmonary Hypertension. Endosomal Acid-Base Homeostasis in Neurodegenerative Diseases. Endo-Lysosomal Cation Channels and Infectious Diseases. Golgi pH and Ion Homeostasis in Health and Disease. Autocrine, Paracrine, and Endocrine Signals That Can Alter Alveolar Macrophages Function.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1